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Abstract
Background: Autism is a neurodevelopmental disorder characterized by impairments in social interaction, verbal
communication and repetitive behaviors. To date the etiology of this disorder is poorly understood. Studies suggest
that astrocytes play critical roles in neural plasticity by detecting neuronal activity and modulating neuronal
networks. Recently, a number of studies suggested that an abnormal function of glia/astrocytes may be involved in
the development of autism. However, there is yet no direct evidence showing how astrocytes develop in the brain
of autistic individuals.
Methods: Study subjects include brain tissue from autistic subjects, BTBR T + tfJ (BTBR) and Neuroligin (NL)-3
knock-down mice. Western blot analysis, Immunohistochemistry and confocal microscopy studies have be used to
examine the density and morphology of astrocytes, as well as Wnt and β-catenin protein expression.
Results: In this study, we demonstrate that the astrocytes in autisitcsubjects exhibit significantly reduced branching
processes, total branching length and cell body sizes. We also detected an astrocytosis in the frontal cortex of
autistic subjects. In addition, we found that the astrocytes in the brain of an NL3 knockdown mouse exhibited
similar alterations to what we found in the autistic brain. Furthermore, we detected that both Wnt and β-catenin
proteins are decreased in the frontal cortex of autistic subjects. Wnt/β-catenin pathway has been suggested to be
involved in the regulation of astrocyte development.
Conclusions: Our findings imply that defects in astrocytes could impair neuronal plasticity and partially contribute
to the development of autistic-like behaviors in both humans and mice. The alteration of Wnt/β-catenin pathway in
the brain of autistic subjects may contribute to the changes of astrocytes.






Autism is a neurodevelopmental disorder characterized
by impairments in social interaction, verbal communica-
tion and repetitive behaviors. But the etiology of this
disorder is poorly understood. Animal models offer
opportunities for conducting biological studies to under-
stand the mechanisms responsible for the phenotypes.
The BTBR T+ tf J (BTBR) mice are currently used as a
mouse model for understanding mechanisms that may
be responsible for the pathogenesis of autism since they
demonstrate the three core autistic symptoms [1-4]. InRE
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reproduction in any medium, provided the oraddition, the Neuroligin-3(NL3) knockdown mouse
may be a useful model for studying autistic-related be-
haviors since this mouse model mimics autistic core
symptoms [5].
The brain consists of two major cell types - neurons
and glial cells. In the past, neurons have been extensively
studied. However, research on glial cells has increased
in the last decade. The development of the nervous
system requires choreographed neuronal migration,
axon guidance, target selection, dendritic growth and
synapse formation.
Proper orchestration of each of these stages of neuronal
development requires glial-derived factors. Glial cells in
the central neural system (CNS) are categorized into
four types, which include astrocytes, oligodendrocytes,. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tive cells. Astrocytes are a very heterogeneous population
of cells, which interact with neurons and blood vessels.
These cells detect neuronal activity and can modulate
neuronal networks. Oligodendrocytes (or Schwann cells in
the peripheral nervous system) form myelin and thus are
prerequisites for the high conduction velocity of axons in
vertebrates. Microglia cells are the immune cells of the
CNS and respond to changes in the environment [6].
Together these cells play essential roles in nervous system
development and function, from simple trophic support of
neurons, and wrapping axons and allowing for rapid nerve
impulse conduction, to modulating synaptic connectivity
and efficacy. During nervous system development, the
neural progenitor cells (NPCs) generate neurons first, fol-
lowed by glia. The switch from neurontoglia at the proper
time is critical for the establishment of normal brain func-
tion. The mechanisms regulating this transition and devel-
opment of glia are complex, and currently are poorly
understood [7]. However, a number of recent studies indi-
cate that the fate switch is governed by both extrinsic en-
vironmental cues that promote astrogenesis in NPCs and
NPC-intrinsic mechanisms that decrease neurogenic and
increase astrogenic competence over developmental time.
The Wnt(wingless-type MMTV integration site1) pathway
has been shown to be required for the activation of the
proneural genes neurogenin1 (ngn1) and neurogenin2
(ngn2) in NPCs, where, at an early stage, they act to pro-
mote neuronal differentiation [8-10]. Recently, Episcopo
et al. demonstrated that Wnt1-regulated Frizzled-1/β-
Catenin signaling pathway can also act as a candidate
regulatory circuit controlling mesencephalic dopaminergic
neuron-astrocyte crosstalk [11]. In addition, it was shown
that Wnt/β-Catenin signaling increases in proliferating
NG2+ progenitors and astrocytes during post-traumatic
gliogenesis in the adult brain [12].
Recently, a number of studies have suggested that ab-
normal functioning of glia/astrocytes may play a role in
the development of autism. Laurence and Fatemi
reported that the glial fibrillary acidic protein (GFAP), a
marker for astrocytes, is elevated in the superior frontal,
parietal and cerebellar cortices of autistic subjects [13].
GFAP was also reported to be three times higher in the
cerebrospinal fluid of autistic and autistic-like conditions
as compared with a control group [14]. In addition, a
study reported that the expression of the astrocytic mar-
kers aquaporin4 and connexin43 are altered in the
brains of subjects with autism. Most recently, a role for
glia in the progression of Rett syndrome (RTT), an X-
linked autism spectrum disorder caused by loss of func-
tion of the transcription factor methyl-CpG-binding
protein 2 (MeCP2), has been reported [15-17]. In these
studies, it was found that mutant astrocytes from anRTT




TEsupport normal dendritic morphology of either wild-
type or mutant hippocampal neurons. It was also shown
that in globally MeCP2-deficient mice, re-expression of
Mecp2 preferentially in astrocytes significantly improved
locomotion and anxiety levels, restored respiratory ab-
normalities to a normal pattern, and greatly prolonged
lifespan compared to globally null mice. Furthermore, a
recent study demonstrated that astrocytes in the fragile
× mouse model induced developmental delays in normal
dendrites including maturation and synaptic protein ex-
pression, and implicated a role for astrocytes in the de-
velopment of the fragile × syndrome [18]. Taken
together, the evidence suggests that glia/astrocytes could
develop or be regulated abnormally in the autistic brain
and that alterations of glia/astrocytes could be critically
involved in the pathogenesis of autism. However, as yet
there is no study directly investigating how astrocytes
develop in the brain of autistic individuals. The aim of
this study was to examine the development and morph-
ology of astrocytes in the brains of autistic subjects, as
well as in the brains of BTBR mice and NL3 knockout
murine models of autism.
Methods
Study subjects
Frozen human brain tissues of six autistic subjects
(mean age ± SD, 8.3 ± 3.8 years) and six age-matched
normal subjects (mean age 8.0 ± 3.7 years) were obtained
from the NICHD Brain and Tissue Bank for Develop-
mental Disorders. Donors with autism fit the diagnostic
criteria of the Diagnostic and Statistical Manual-IV, as
confirmed by the Autism Diagnostic Interview-Revised.
Participants were excluded from the study if they had a
diagnosis of fragile × syndrome, epileptic seizures,
obsessive-compulsive disorder, affective disorders, or any
additional psychiatric or neurological diagnoses. This
study was approved by the Institutional Review Board of
the NY State Institute of Basic Research and the sub-
jects’ information is summarized in Table 1.
Six BTBR T+ tfJ (BTBR) mice and six age- and sex-
matched B6 mice (7 weeks old) were obtained from the
Jackson Laboratories (Bar Harbor, ME, USA). Mice were
housed for 24 hours with food and water ad libitumto
ease the stress before sacrifice. Then the mice were rap-
idly sacrificed with cervical dislocation for removal of
the brains. All procedures were conducted in compliance
with the NIH Guidelines for the Care and Use of La-
boratory Animals and approved by the New York State
Institute for Basic Research Institutional Animal Care
and Use Committee.
The NL3 mouse was obtained by microinjection of
neuroligin 3 RNAi into the fertilized CD-1 mouse and
then transferring to the oviduct of CD-1 mice. PCR ana-






Table 1 Study subject information
Case Age Sex Group PMI(h) Seizure Retardation Medication Cause of death
1 7 M Control 12 - - Concerta, Clonidone Drowning
2 8 M Control 36 - - - Drowning
3 4 F Control 21 - - - Lymphocytic myocarditis
4 9 F Control 20 - - Albuterol, Zirtec Asthma
5 6 M Control 18 - - - Multiple injuries
6 14 M Control 16 - - - Cardiac arrhythmia
7 7 M Autism 20 - - - Drowning
8 8 M Autism 16 - - - Drowning
9 4 F Autism 13 - - - Multiple injuries
10 9 F Autism 24 - - - Smoke inhalation
11 8 M Autism 12 - + - Drowning
12 14 M Autism 12 + + - Drowning
M, male; F, female; PMI (h) (Post-Mortem Intex).
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IC
LEsurrogate NL3 knockdown mouse. A number of behav-
ioral tests including open field test, elevated plus maze,
water maze, vocalization test and social behavior test
were carried out to determine the mouse behavior. The
NL3 mouse exhibited increased anxiety, impaired cogni-
tion, vocal communication deficits and decreased social
interaction, compared with the age- and sex-matched lit-
termate control mice (unpublished data).Preparation of brain homogenates
The frontal cortex and cerebellum were dissected. The
frozen frontal cortex and cerebellum tissues were
homogenized (10% w/v) in cold buffer containing
50 mMTris–HCl (pH 7.4), 8.5% sucrose, 2 mM EDTA,
10 mM β-mercaptoethanol and a protease inhibitor
cocktail (Sigma-Aldrich St. Louis, MO USA). The pro-





Paraffin sections (6 μm)were deparaffinized with xylene
(2×), ethanol of 100% (2×), 80%, 50%, and 25% concen-
tration and washed in TBS, 5 minutes each time. The
sections were then incubated with primary antibodies
overnight at 4°C. After washing in TBS for 5 minutes,
the sections were further incubated with secondary anti-
body (biotinylated horse anti-mouse IgG, or biotinylated
horse anti-rabbit IgG, VectaStain Elite ABC Kit,
Vector Lab Burlingame, CA, USA) for 30 minutes at
room temperature, followed by incubation in Avidin-
biotinylated peroxidase (VectaStain Elite ABC Kit) for
45 minutes at room temperature and in 0.0125 g DAB/
25 ml 0.05 M TBS/1 drop 30% H2O2 for 10 minutes at
room temperature. All sections were washed in sequence
with TBS, 25%, 50%, 80%, and 100% ethanol (2×) and
RE
TRxylene (2X) before mounting for viewing under the
microscope.
Western blot analysis
Brain homogenate samples in SDS sample buffer (20%
glycerol, 100 mMTris, pH 6.8, 0.05% Bromophenol blue
(w/v), 2.5% SDS (w/v), 250 mM DTT) were denatured
by heating at 100°C for 5 minutes. Twenty to sixty
micrograms of protein per lane per subject were loaded
onto a 10% acryl-bisacrylamide gel and electrophoresed
for 2 hours at 110 V at room temperature. The separated
proteins were electroblotted onto a polyvinylidenedi-
fluoridePVDF membrane for 1 hour at 100 V at room
temperature. Protein blots were then blocked with 5%
non-fat milk in PBS with 0.1% Tween-20 (PBST). After
blocking, the blots were incubated with primary anti-
body overnight at 4°C followed by secondary antibody
incubation for 1 hour at room temperature (goat ant-
mouse IgG or goat anti-rabbit IgG, horse radish peroxid-
ase (HRP)-conjugated, 1:5000, Sigma). After three
washes in PBST (10 minutes each time), the blots were
exposed to Hyper film ECL. Sample densities were ana-
lyzed with Image J software (NIH), an open domain Java
image processing system. The densities of the protein
expression bands, as well as the β-actin expression bands
were quantified with background subtraction.
Confocal microscopy and data analysis
Immunostaining images were visualized using a laser-
scanning confocal microscope to obtain clear pictures
(Nikon Eclipse 90I, 10 × 40 maglification, IBR-
Microscopy Shared Research Facility). Image J analysis
was used to calculate area and immunostaining density.
Quantification of western blot analysis was performed
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Statistical analysis was conducted using SPSS 13.0 soft-
ware. Means, standard deviations and standard errors of
the mean were determined in sets of study subjects versus
control subjects. The unpaired t-test was used to compare
each parameter measured and P values were determined.
P< 0.05 was considered statistically significant.
Results
The density and morphology of astrocytes were
significantly changed in the frontal cortex of
autistic subjects
With immunohistochemistry studies using anti-GFAP anti-
body, and employing confocal microscopy, we observed
that the number of astrocytes was clearly increased.
Quantitative analysis conducted on the brain slices from
six autistic subjects and six age-matched normal controls
showed that the density of astrocytes was increased ap-
proximately 1.6-fold in the frontal cortex of autistic sub-
jects compared with age-matched controls (P=0.035,
Figure 1A). We also observed that the astrocyte morph-
ology was grossly changed in the autistic cortex. With
Image J analysis, we showed that the number of astrocytic
branch processes radiating from the cell body was signifi-
cantly decreased by 60.2% in the autistic subjects com-
pared with the controls (P=0.027, Figure 1A). The total
branching length was significantly decreased by 71% com-
pared with the controls (P=0.007, Figure 1A). WeFigure 1 The morphology and density of astrocytes were significantly
Immunohistochemistry studies were carried out on frontal cortex (A) and c
controls using an anti-glial fibrillary acidic protein (GFAP) antibody (dilution
power (HP). Immunostaining of GFAP (dark brown color) was present in all
processes, cell body size and the total branch length were quantified using




TEexamined cell body sizes and found that the mean cell
body size of the autistic subjects was decreased by 37%
compared to controls (P=0.0001, Figure 1A). We exam-
ined cerebellar astrocytes of both autistic and control sub-
jects. Our results demonstrated that their density and
morphology were not significantly different in the autistic
cerebellum compared with the controls (P=0.088 for
density of astrocytes; P=0.065 for branch processes;
P=0.349 for total branch length and P=0.124 for cell
body size, Figure 1B).
The density and morphology of astrocytes in the brain of
BTBR mice
Since BTBR mice exhibit autistic-like behaviors and are
currently used as a mouse model to study autism, we
examined whether their astrocytes have similar changes.
Our results analyzed from six BTBR mice and six age-
matched B6 mice showed that the density of astrocytes
in the brain of BTBR mice was not significantly changed
compared with control B6 mice(P= 0.069, Figure 2). In
addition, we also examined the morphology of astrocytes
in both BTBR and control B6 mice. With Image J ana-
lysis, we showed that the number of astrocytic branch
processes in BTBR mice was not significantly different
compared with B6 mice (P= 0.11, Figure 2). Both the
total branching length and cell body size also remained
unchanged in BTBR mice compared with the B6 mice





Echanged in the frontal cortex of autistic subjects.
erebellum sections (B) from six autistic subjects and six age-matched
1:1000). Pictures were taken under both low power (LP) and high
astrocytes. The density of astrocytes, number of astrocytic branch
Image J analysis. *P< 0.05, ***P< 0.001. Scale bar: 20 μm. Data are
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astrocytes in BTBR mice are not significantly altered
compared with B6 mice.
To further confirm the results, we examined the
GFAP expression level in the brain of BTBR and B6
mice with western blot analyses. Our results demon-
strated that there are no significant differences in the
GFAP expression between the frontal cortex (P= 0.12),
as well as the cerebellum (P= 0.36) of BTBR and B6
mice (Figure 3).
The morphology of astrocytes was altered in the brain of
a NL3 knockdown mouse
In this study, we only obtained one NL3 knockdown B6
mouse. These mice exhibit autism-like behaviors in-
cluding increased anxiety, impaired cognition, vocalFigure 2 The density and morphology of astrocytes in the brain of BT
brain sections from six BTBR mice and six age-matched control B6 mice us
1:1000). Immunostaining of GFAP (dark brown color) was present in all astr





TEcommunication deficits and decreased social interac-
tions. We found that the astrocytes in the frontal cortex
of the NL3 knockdown mouse exhibited similar
changes to those that we observed in the frontal cortex
of autistic subjects. We found that the number of astro-
cytic branch processes was decreased by 41.3% in the
NL3 knockdown mouse compared with the control B6
mouse (P = 0.01, Figure 4). The total branching length
was also decreased by 52.6% compared with the control
B6 mice (P = 0.022, Figure 4). In addition, we found that
the mean value of the cell body size in the NL3 knock-
down mouse was decreased by 43.7% compared with
the control B6 mouse (P = 0.020, Figure 4). However,
the density of astrocytes in the NL3 knockdown mouse
was not significantly changed compared with the con-
trol B6 mouse (P = 0.11, Figure 4).IC
LEBR mice. Immunohistochemistry studies were carried out on whole
ing an anti-glial fibrillary acidic protein (GFAP) antibody (dilution
ocytes. The density of astrocytes, number of astrocytic branch
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brain of autistic subjects
Since the Wnt/β-catenin pathway has been suggested to
play a role in controlling mesencephalic dopaminergic
neuron-astrocyte crosstalk and is involved in the modula-
tion of gliogenesis, we examined how the Wnt/β-catenin
pathway is regulated in the autistic brain. By immunohis-
tochemistry studies using anti-Wnt antibodies, we
observed by confocal microscopy that the immunostaining
was weaker in the neuronal cells of the frontal cortex of
autistic subjects compared with the controls. Quantitative
analysis showed that the immunoreactivity of Wnt was
decreased in the autistic brain by 61% compared with the
controls (P=0.037, Figure 5). In addition, western blot
studies were conducted to examine β-catenin protein ex-
pression in the brain of autistic subjects. Our results
demonstrated that the mean value of β-catenin protein ex-
pression was decreased by 24.7% in the frontal cortex of
autistic subjects (P=0.002, Figure 5), but was not signifi-
cantly changed in the autistic cerebellum compared with
controls (data not shown). These results suggest that Wnt/
β-catenin signaling activities may be down-regulated in the
frontal cortex of autistic subjects.Figure 3 GFAP protein expression in the frontal cortex of BTBR and B
cerebellum homogenates from six BTBR mice and six age-matched B6 mic
1:1000). The blots on cortex and cerebellum were quantified respectively a





Previously, a number of studies have suggested that ab-
normal functioning of glia and astrocytes may play a role
in the development of autism. GFAP expression, a mar-
ker for astrocytes, has been reported to be significantly
elevated in the cortex and cerebrospinal fluid of autistic
subjects [13,14]. Other astrocyte markers such as aqua-
porin 4 and connexin 43 have also been shown to be
altered in the brains of autistic individuals [20]. In par-
ticular, several recent studies have demonstrated that the
abnormal functions of glia may also contribute to the
progression of RTT, an X- linked autism spectrum dis-
order, and to the fragile X syndrome [15-18]. However,
to date the information about glia/astrocyte develop-
ment and function in the autistic brain is very limited.
In this study, by employing western blotting and immu-
nohistochemical approaches, we found that the morph-
ology of astrocytes in the frontal cortex of autistic
subjects was markedly altered compared with controls.
The astrocytes in the autistic cortex exhibited signifi-
cantly reduced branching processes, and the total branch
length as well as the cell body size were significantly
decreased. Further, the number of astrocytes was
RT
IC
LE6 mice. Western blot analyses were carried out on frontal cortex and
e using anti-glial fibrillary acidic protein (GFAP) antibody (dilution




Figure 4 The morphology of astrocytes was altered in the frontal cortex of NL3 knockdown mice. Immunohistochemistry studies were
carried out on the whole brain sections from one NL3 knockdown mouse and one age-matched control littermate using an anti-glial fibrillary
acidic protein (GFAP) antibody (dilution 1:1000). Immunostaining of GFAP (dark brown color) was present in all astrocytes. The density of
astrocytes from the frontal cortex, as well as the number of astrocytic branch processes, cell body size and the total branch length were
quantified using Image J analysis. *P< 0.05. Scale bar: 10 μm. Data are shown as mean± standard error (SE).








LEmarkedly increased compared with the controls. These
results indicate that there is an astrocytosis in the autis-
tic brain, and the structures of the astrocytes are altered.
Astrocytes are the most abundant cells in the CNS
and have been suggested to detect neuronal activity
and modulate neuronal networks. Thus their struc-
tural integrity and sustained function are essential for
neuronal viability [21-23]. The astrocyte branching
processes are important structures, which can inter-
digitate between and closely approximate adjacent
neuronal elements, thereby facilitating the local
homeostasis of a range of molecules, including glu-
tamate [24-26]. Studies have shown that the neurons
RE
T depend upon the physical proximity of the astrocyte
processes for normal function [23]. Torres-Plataset al.
also reported that changes in astrocyte structures in-
cluding branching processes, and cell body sizes may
be significantly involved in mood disorders [27].
Thus, we suggest that the interruption of the astro-
cyte structures in the autistic cortex could critically
impair neuronal function and the homeostasis of cer-
tain molecules such as glutamate, which may lead to
the development of autistic-like behaviors.
Recently, studies have also shown that astrocytes have
a complex, dual role in the local regulation of immune
reactivity. They form the glia limitans around blood
Figure 5 Wnt and β-catenin protein expression in the brain of autistic subjects. Upper panel: western blot analyses were carried out on
frontal cortex homogenates from six autistic subjects and six age- and sex-matched controls using an anti-β-catenin antibody (dilution 1:1000)
(5A). The blots were quantified after being normalized by actin (5B). Data are shown as mean± standard error (SE). **P< 0.01. Lower panel:
immunohistochemistry studies were carried out on frontal cortex sections from six autistic subjects and six age-matched controls using an anti-
Wnt antibody (dilution 1:100). Weaker immunostaining of Wnt protein (dark brown color as indicated by arrows) was present in the autistic
subjects compared with the controls (5C). Immunostaining density was quantified using Image J analysis (5D). Data are shown as
mean± standard error (SE). *P< 0.05. Scale bar: 20 μm.





LEvessels restricting the access of immune cells to the CNS
parenchyma [28]. Astrocytes have also been shown to be
important regulators of neuroinflammation. Previous
studies have demonstrated that astrocytes carry a series
of germline-encoded pattern-recognition receptors (PRRs),
which are important for the primary recognition of infec-
tious agents [29]. Several cytokines, including IL-1 and
IL-6, have been implicated in the induction and modulation
of reactive astrogliosis and pathological inflammatory res-
ponses [30-34]. In addition, astrocytes have been reported
to secrete inflammatory cytokine IL-6 [35]. Recently, vari-
ous studies have suggested that abnormal immunity and
localized inflammation of the central nervous system may
contribute to the pathogenesis of autism. A number of
studies including ours have demonstrated that cytokines in-
cluding IL-6, IL-1β TNF-α and IFN-γ are elevated in the
serum and brain tissue of autistic individuals [35-41]. We
reckon that the astrocytic changes could result from an in-
flammatory process.
It will be important to determine whether the
observed changes in astrocyte structure, as well as the
astrocytosis found in the autistic brain are associated
with elevated inflammatory cytokines such as IL-6. In
this study, we did not determine the IL6 concentration
in the same sample used for examining the astrocytes.
Further studies can be conducted to examine cytokines




TEthe same time. We suggest that it is also possible that
the increased cytokines, in particular IL-6 in the autistic
brain, could result from the astrocytosis.
We next undertook to determine whether the
alterations in the structure and density of astrocytes
in the autistic brain also occurred in murine models
of autism, including NL3 knockdown mice and BTBR
mice. We found that the morphology of astrocytes in
the NL3 knockdown mouse exhibited similar changes
to that found in the autistic brain. They exhibit signifi-
cantly reduced branching processes and total branch
lengths, and as well the astrocytic cell body sizes were sig-
nificantly decreased in comparison with the controls.
Neuroligins are cell adhesion molecules localized postsy-
naptically in glutamatergic synapses, and interact with
presynaptic neurexins to form heterophilic complexes,
which likely play critical roles in synaptic transmission
and differentiation of synaptic contacts [42-45]. A role of
neuroligins in autism was implied by the discovery of dele-
tions at Xp22.1 containing the NL4X gene in three female
autistic individuals and a missense mutation (R451C) in
NL3 in two Swedish families with autism [46,47]. NL3
knockdown mice have been shown to mimic certain
human autistic behaviors [5]. Recent studies have demon-
strated that NL3 is expressed in many types of glia during
the development of the nervous system. In particular, NL3
is expressed in the olfactory ensheathing glia, retinal
D
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developing embryo [48]. The NL3 knock-down mouse in
the current study was shown to exhibit autistic-like beha-
viors including increased anxiety, impaired cognition, vocal
communication deficits and decreased social interactions
(unpublished data). Thus, there is a possibility that alter-
ation in astrocyte structure could be partially responsible
for the development of autistic-like behavior in NL-3
knockdown mice. The mechanisms through which struc-
tural change in astrocytes could lead to behavioral changes
remains to be further investigated. A limitation of this study
was that we only had one NL3 knockdown mouse that
could be analyzed. More studies are needed to further con-
firm our observations.
We did not detect a significant change in the
morphology of astrocytes in either the cortex or cere-
bellum of the BTBR mice, another murine model of
autism. There were no significant differences in the
number of astrocyte branching processes, the total
length of processes orcell body size between the BTBR
and control B6 mice. Nor did we find that there was
an astrocytosis in the brain of BTBR mice similar to
that found in the autistic brain. The density of astro-
cytes remained unchanged compared with the control
mouse. However, we have not examined the orienta-
tion of the glial fibers. Recently, it was reported that
there is a misorientation of selected glial fibers present
in the BTBR forebrain [49]. This study found that the
astrocytic processes were oriented dorsoventrally rather
than mediolaterally in the cingulum and alveus at the
levels of the striatum and hippocampus. The misorien-
tation of glial processes was only found in brain
regions that normally receive corpus callosal innerva-
tions, indicating that these findings are likely to be a
consequence of callosal agenesis [49]. We therefore
reason that although there are no changes observed in
the astrocyte density, as well as in the number of
branching processes and cell body sizes in BTBR mice,
a misorientation of glial processes could lead to
impairments in the functions of astrocytes, and conse-
quentially impair synaptic plasticity and various neural
functions and might contribute to the development of
autistic-like behaviors. It has been demonstrated that
astrocyte secreted proteins selectively increase hippo-
campal GABAergic axon length, branching, and synap-
togenesis [50]. Whether the change in astrocytes in
autistic subjects, or NL3 knockdown and BTBR mice
could impair the development of GABAergicaxons,
remains to be further studied.
Both NL3 knockdown and BTBR mice have been
demonstrated to exhibit core autistic-like behaviors.
Alterations found in the astrocytes of autistic subjects
and the mice models imply that NL3 knockdown mice




TEbiological studies to understand the mechanisms respon-
sible for autism.
More and more evidence suggests that astrocytes are
intimately associated with synapses and govern key steps
in synapse formation and plasticity. However, we under-
stand little about the molecular underpinnings of astro-
cyte development. It is unclear how astrocytes are
specified at the appropriate developmental time from
NPCs and how their development and maturation are
regulated. The Wnt/β-catenin signaling pathway has
been intensely studied as a key regulator of cell prolif-
eration and cell fate during development, including
neural development [10,23,51-53]. Recently, several
studies have reported a role of Wnt/β-catenin signaling
in the development of astrocytes [12]. It has been shown
that Wnt/β-catenin pathway signaling regulates post-
traumatic gliogenesis. Wnt/β-catenin pathway has also
been demonstrated to act as a candidate regulatory cir-
cuit that controls mesencephalic dopaminergic neuron-
astrocyte crosstalk [11]. In this study, we found that
both Wnt and β-catenin protein expression were
decreased in the brains of autistic subjects, suggesting
that Wnt/β-catenin signaling activities are down-regu-
lated. There is some evidence for a direct genetic link
between Wnt2 and autism spectrum disorders. Two
studies have found correlations between mutations of
the WNT2 locus and the incidence of autism in different
populations [54,55]. Wnt2 has also been found to be
expressed at lower levels in a mouse model of fragile X
syndrome, a human disease strongly associated with aut-
ism [56]. Our findings imply that the decreased expres-
sion of Wnt and β-catenin may be associated with
changes in astrocytes in the frontal cortex of autistic
subjects. Further studies will be carried out to determine
whether down-regulation of Wnt/β-catenin impairs the
structure and density of astrocytes.
Conclusion
In summary, our study demonstrated that the morph-
ology of astrocytes in the frontal cortex of autistic sub-
jects was significantly altered compared with age- and
sex-matched controls. The astrocytes in autisitc subjects
exhibited significantly reduced branching processes,
reduced total branching lengths and decreased cell body
sizes. In addition, we detected astrocytosis present in the
frontal cortex of autistic subjects. However these altera-
tions of astrocytes are not detected in the autistic cere-
bellum. Interestingly, we found that astrocytes in the
frontal cortex of the NL3 knockdown mouse also
showed significantly reduced branching processes,
reduced total branching length and decreased cell body
sizes, which mimic the changes in the autistic brain.
These findings imply that the defects in astrocytes could
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behaviors in both humans and mice. We did not detect
significant alterations in the density and morphology of
astrocytes from the frontal cortex or cerebellum of
BTBR mice. Recently, one study reported that there is a
misorientation of selected glial fibers present in the
BTBR forebrain. We suggest that even small changes like
misorientation of glial fibers could affect astrocyte func-
tions and consequently neuronal networks and lead to
behavioral changes. Finally, we found that both Wnt
and β-catenin protein expression was decreased in the
brains of autistic subjects, which suggests that the Wnt/
β-catenin signaling activities may be down-regulated. We
suggest that the alteration of the Wnt/β-catenin pathway
in the frontal cortex of autistic subjects could be one of
the underlying mechanisms responsible for the observed
changes of astrocytes. Our findings indicate that astrocytes
may play an important role in the development of autism
and may further suggest new potential therapeutic targets
and strategies for intervention in autism.
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